直肠癌新辅助放疗后直肠切除术淋巴结检出数:系统评价与荟萃分析
该系统评价与荟萃分析检索1980年1月1日至2015年3月31日PubMed、EMBASE和Cochrane Library,纳入34篇文章(37个数据集),量化新辅助放化疗或单纯放疗对直肠癌患者淋巴结检出数的影响。新辅助放化疗较未接受新辅助治疗者平均减少3.9枚淋巴结(95%CI 3.7-4.1),阳性淋巴结平均减少0.7枚(95%CI 0.2-1.2);单纯新辅助放疗者平均减少2.1枚淋巴结(95%CI 1.7-2.5)。作者强调外科医生和病理科医生应共同努力达到现行指南12枚淋巴结的基准检出数。
要点
- 新辅助放化疗较未接受新辅助治疗者淋巴结检出数平均减少3.9枚(95%CI 3.7-4.1)。
- 单纯新辅助放疗较未接受新辅助治疗者淋巴结检出数平均减少2.1枚(95%CI 1.7-2.5)。
- 新辅助放化疗较未接受新辅助治疗者阳性淋巴结检出数平均减少0.7枚(95%CI 0.2-1.2)。
核心结论
- 直肠癌患者接受新辅助放化疗或单纯放疗分别导致淋巴结检出数减少约4枚和2枚。
- 作者强调相关亚专科(外科医生和病理科医生)应加强努力,达到现行指南12枚淋巴结的基准检出数。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、EMBASE和Cochrane Library,无语言限制,检索时间为1980年1月1日至2015年3月31日。
- 共纳入34篇文章(包括37个数据集),比较接受新辅助治疗与未接受新辅助治疗患者的淋巴结计数或阳性淋巴结检出数。
- 由两名评价者独立审查所有发表文献并提取相关数据,采用荟萃分析量化淋巴结检出数的平均差值。
主要发现
- 与未接受新辅助治疗者相比,新辅助放化疗者淋巴结检出数平均减少3.9枚(95%CI 3.7-4.1)。
- 与未接受新辅助治疗者相比,新辅助放化疗者阳性淋巴结检出数平均减少0.7枚(95%CI 0.2-1.2)。
- 与未接受新辅助治疗者相比,接受新辅助放疗者淋巴结检出数平均减少2.1枚(95%CI 1.7-2.5)。
关键数值与推荐
- 现行指南的淋巴结检出基准为12枚。
临床怎么用
- 作者强调相关亚专科(即外科医生和病理科医生)应加强所有努力,以达到现行指南12枚淋巴结的基准检出数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The lymph node status represents a major prognostic factor in colorectal cancer. However, it was demonstrated that neoadjuvant chemoradiotherapy (CRT) decreases the numbers of lymph nodes in the specimen. Several studies describe less than 12 lymph nodes in the resected specimen of rectal cancer patients after neoadjuvant radiation. This meta-analysis quantifies the influence of neoadjuvant CRT or radiotherapy (RT) only on the lymph node yield in rectal cancer patients. METHODS: We performed a systematic review and searched PubMed, EMBASE and the Cochrane Library without any language restriction from 1st of January 1980 until 31st March 2015. Two reviewers examined all publications independently and extracted the relevant data if the study assessed lymph node counts or positive lymph node yields of patients who received neoadjuvant treatment compared with patients who did not receive neoadjuvant treatment. Meta-analyses were conducted to quantify the mean difference in lymph node yield. RESULTS: A total of 34 articles (including 37 datasets) were included in the meta-analyses. Neoadjuvant CRT resulted in a mean reduction of 3.9 lymph nodes (95% confidence interval [CI] 3.7-4.1) and an average reduction in harvested positive lymph nodes of 0.7 (95% CI 0.2-1.2) compared with patients who received no neoadjuvant therapy. Individuals who received neoadjuvant RT had, in average, 2.1 lymph node less (95% CI 1.7-2.5) resected compared with their counterparts who received no neoadjuvant treatment. CONCLUSIONS: Neoadjuvant CRT or RT only in rectal cancer patients leads to a decrease in lymph node harvest of approximately four and two lymph nodes, respectively. We therefore stress the importance of intensifying all efforts from involved subspecialities (i.e. surgeons and pathologists) to reach the benchmark harvest of 12 resected lymph nodes according to current guidelines.
引用
- Mechera R, Schuster T, Rosenberg R, et al. Lymph node yield after rectal resection in patients treated with neoadjuvant radiation for rectal cancer: A systematic review and meta-analysis. Eur J Cancer. 2016. PMID: 28027520. doi:10.1016/j.ejca.2016.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。